Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring the Effects of Treatment With Stellest Lenses and Low-concentration Atropine for Myopia Control Among Children.

NCT06344429 is registered in ClinicalTrials.gov with Essilor-Polylite Taiwan Co., Ltd. as lead sponsor.

NCT NCT06344429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06344429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring the Effects of Treatment With Stellest Lenses and Low-concentration Atropine for Myopia Control Among Children.
Lead sponsor
Essilor-Polylite Taiwan Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
August 20, 2023
Completion date
August 20, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myopia